ALKERMES | Capital Social E Reservas





Capital Social e Reservas Alterar Data
AbbVie USD -2.64B 2.46B 2025-09
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
ALKERMES USD 1.73B 108.85M 2025-09
Amgen USD 9.62B 2.19B 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 23.79B 5.52B 2025-09
Gilead Sciences USD 21.46B 1.78B 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 78.47B 0 2025-09
Malin Corporation EUR 193.2M 75M 2024-12
Merck USD 51.85B 2.79B 2025-09
Neurocrine Biosciences USD 3B 309.3M 2025-09
Otsuka Holdings JPY 2.86T 136.72B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 30.96B 1.02B 2025-09
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09


ALKERMES Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.